Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSAnti-NASH agent 1 is an anti-non-alcoholic steatohepatitis (NASH) agent and a derivative of the PPARα and PPARδ agonist GFT505 (elafibranor; Item No. 23508).1 It inhibits free fatty acid-induced triglyceride accumulation and aspartate aminotransferase (AST) activity in HepG2 cells when used at a concentration of 40 µM. Anti-NASH agent 1 (3-30 mg/kg) decreases disease severity, reduces serum triglyceride, total cholesterol, LDL, Ast, alanine transaminase (Alt), TNF-α, IL-6, and IL-8 levels, and increases serum HDL and liver glutathione (GSH) levels in a mouse model of NASH induced by a methionine- and choline-deficient diet.
WARNING This product is not for human or veterinary use.
1. Design, synthesis and anti-